Abstract: A polymeric construct is disclosed. The construct comprises a polysaccharide polymer having a selected medicament associated therewith. The medicament thus present is provided in a slow release form.

Abstract: A method of treating a systemic disease in a patient in need of such treatment is disclosed. The method comprising maintaining the inspiratory flow rate and volume of the patient to a certain value and then administering a medicament aerosol formulation to the patient using a breath activated inhalation device.

Abstract: A polymeric construct is disclosed. The construct comprises a biodegradable ABA block copolymer having a selected medicament associated therewith. The medicament thus present is provided in a slow release form.

Abstract: A method of treating in a human or animal a condition capable of treatment by oral or nasal inhalation has been found. The method comprises administering a medicinal aerosol formulation comprising a selected medicament under conditions where the amount of the selected drug delivered to the site of action, e.g. the lungs, is maximized.

Abstract: A polymeric construct is disclosed. The construct comprises a polymer selected from silica gel, fumed silica gel, silicic acid, disilicic acid, trisilicic acid, metasilicic acid, and orthosilicic acid in their free or salt forms; silicon dioxide in either of its amporphous, crystalline, or precipitated forms such as Purified Siliceous Earth; diatomacous earth; Fuller's earth, Kieselhurh, Celite; talc; attapulgite; micas; montmorilonite, kaolin, aluminum oxide (Hydrargilite), bentonite, pumice; silanes and siloxanes and any mixture of the foregoing having a selected medicament associated therewith. The medicament thus present is provided in a slow release form.

Abstract: A medicinal formulation is disclosed. The formulation comprises (a) a protein or peptide medicament; (b) a fluid carrier for containing said medicament; and a stabilizer selected from an amino acid, a derivative thereof or a mixture of the foregoing.

Abstract: A modulated release aerosol formulation is disclosed. The formulation comprises a polysaccharide polymer having a selected medicament associated therewith, a fluid carrier for carrying and delivering the construct and a stabilizer.

Abstract: A modulated release aerosol formulation is disclosed. The formulation comprises a polymer, e.g. silica gel, fumed silica gel, having a selected medicament associated therewith, a fluid carrier for carrying and delivering the construct and a stabilizer.

Abstract: This invention relates to a modulating formulation comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g. metformin, at least a portion thereof has a layer or coat thereon of pioglitazone.

Abstract: A medicinal formulation is disclosed. The formulation comprises (a) a salt/ion pair of a protein peptide medicament; and (b) a fluid carrier for containing said medicament.

Abstract: A modulated release aerosol formulation is disclosed. The formulation comprises a polymer, e.g. Silica gel, fumed silica gel, having a selected medicament associated therewith, and a fluid carrier for carrying and delivering the construct.

Abstract: A modulated release aerosol formulation is disclosed. The formulation comprises a polymer, e.g. Silica gel, fumed silica gel, having a selected medicament associated therewith, and a fluid carrier for carrying and delivering the construct.

Abstract: This invention relates to a controlled-release combination drug product comprising troglitazone, e.g. its hydrochloride, and a biguamide, e.g. metformin. In particular, the product comprises a core of metformin, at least a portion thereof has a layer or coat thereon of troglitazone.

Abstract: This invention relates to a controlled release combination drug product comprising troglitazone, e.g. its hydrochloride, and a biguamide, e.g. metformin. In particular, the product comprises a core of metformin, at least a portion thereof has a layer or coat thereon of troglitazone.

Abstract: A polymeric construct is disclosed. The construct comprises a polymer selected from sililc gel, fumed silica gel, silica acid, trisilicic acid, metasilicic acid, and orthosiscic acid in their free or salt forms; silicon ioxide in either of its amporphous, crystalline, or precipitated forms such as Purified Siliceous Earth; diatomacous earth; Fuller's earth, Kieselhurh, Celite; talc; Attapulgite; micas; montmorilonite, kaolin, aluminum oxide (Hydrargilite), bentonite, pumice; silanes and silaxanes and any mixture of the foregoing having a selected medicament associated therewith. The medicament thus present is provided in a slow release form.

Abstract: A method and system enables optimal call routing in a satellite communications network when a satellite subscriber has, for example, call forwarding active. Many satellite networks re-register a satellite subscriber's (e.g., the A-subscriber's) subscription information to a satellite gateway that is most cost efficient when the satellite subscriber initiates an outgoing call. If the called party (e.g. the B-subscriber) is distant from the satellite subscriber's home country, the distant gateway to which the re-registration occurs is likely to be far from the gateway of his or her native country, which is often to where call forwarding is directed. When an incoming call from a C-subscriber is detected for the A-subscriber, the call is handled normally until call forwarding is detected in the distant gateway. Once call forwarding is detected, a satellite gateway through which the call will be completed (e.g.

Abstract: A modulated release aerosol formulation is disclosed. The formulation comprises a polymer, e.g. Silica gel, fumed silica gel, having a selected medicament associated therewith, and a fluid carrier for carrying and delivering the construct.

Abstract: A modulated release aerosol formulation is disclosed. The formulation comprises a polymer, e.g. silica gel, funed silica gel, having a selected medicament associated therewith, a fluid carrier for carrying and delivering the construct and a stabilizer.

Abstract: A modulated release aerosol formulation is disclosed. The formulation comprises a polysaccharide polymer having a selected medicament associated therewith, a fluid carrier for carrying and delivering the construct and a stabilizer.

Abstract: A modulated release aerosol formulation is disclosed. The formulation comprises a polymer, e.g. Silicia gel, fumed silicia gel, having a selected medicament associated therewith, and a fluid carrier for carrying and delivering the construct.